|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.318
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.170
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.161
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.160
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.153
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.153
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.141
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.137
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.137
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.136
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.130
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.129
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.118
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.115
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.114
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.114
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.112
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.112
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.110
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.110
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.108
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.107
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.106
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.105
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.104
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.104
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.103
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.103
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.102
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.101
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.101
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.100
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.099
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.097
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.097
|
Mouse |
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.097
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.097
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.096
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.096
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.094
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.093
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.093
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.092
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.091
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.088
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.088
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.087
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.087
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.087
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.087
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.087
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.086
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.086
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.085
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.084
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.084
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.084
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.084
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.083
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.082
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.082
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.081
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.081
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.080
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.079
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.079
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.078
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.078
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.077
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.077
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.077
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.076
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.076
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.075
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.075
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.074
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.073
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.073
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.071
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.071
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.071
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.071
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.070
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.070
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.070
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.070
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.069
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.068
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.068
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.066
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.066
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.066
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.066
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.066
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.066
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.065
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.065
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.064
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.064
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.063
|
|
|
|
positive regulation of smoothened signaling pathway
|
GO:0045880 |
23 |
0.062
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.062
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.061
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.061
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.061
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.060
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.060
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.060
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.059
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.059
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.058
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.058
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.058
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.057
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.057
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.057
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.057
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.056
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.056
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.056
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.056
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.056
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.055
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.055
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.055
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.054
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.054
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.054
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.054
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.054
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.052
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.052
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.052
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.051
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.051
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.051
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.051
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.051
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.050
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.050
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.050
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.050
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.050
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.050
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.049
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.049
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.049
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.049
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.049
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.048
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.048
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.048
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.048
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.048
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.048
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.047
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.047
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.047
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.047
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.047
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.047
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.047
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.047
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.046
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.046
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.046
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.045
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.045
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.045
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.045
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.045
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.045
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.044
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.044
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.044
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.044
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.044
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.044
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.044
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.044
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.043
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.043
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.043
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.043
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.043
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.042
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.042
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.042
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.041
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.041
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.041
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.041
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.040
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.040
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.040
|
|
|
|
anatomical structure regression
|
GO:0060033 |
9 |
0.040
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.040
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.040
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.040
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.040
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.040
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.039
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.038
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.038
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.038
|
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.038
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.038
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.038
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.038
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.038
|
|
|
|
cerebral cortex radial glia guided migration
|
GO:0021801 |
17 |
0.037
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.037
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.037
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.037
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.037
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.037
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.037
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.036
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.036
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.036
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.036
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.036
|
|
|
|
renal capsule specification
|
GO:0072130 |
1 |
0.036
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.036
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.036
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.036
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.036
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.036
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.035
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.035
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.035
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.035
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.035
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.035
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.035
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.035
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.035
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.035
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.035
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.035
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.035
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.035
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.034
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.034
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.034
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.034
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.034
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.034
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.033
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.033
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.033
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.033
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.033
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.033
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.033
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.033
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.033
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.033
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.032
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.032
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.032
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.032
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.032
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.032
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.032
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.032
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.032
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.032
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.032
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.032
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.032
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.032
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.032
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.032
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.032
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.031
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.031
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.031
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.031
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.031
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.031
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.031
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.031
|
|
|
|
female somatic sex determination
|
GO:0019101 |
1 |
0.031
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.031
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.030
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.030
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.030
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.030
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.030
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.030
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.030
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.030
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.030
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.030
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.030
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.030
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.030
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.030
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.030
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.030
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.030
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.030
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.030
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.029
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.029
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.029
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.029
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.029
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.029
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.029
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.029
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.029
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.029
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.029
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.029
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.029
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.029
|
Fly |
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.029
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.029
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.029
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.029
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.028
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.028
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.028
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.028
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.028
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.028
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.028
|
|
|
|
regulation of axon diameter
|
GO:0031133 |
6 |
0.028
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.028
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.028
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.028
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.027
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.027
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.027
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.027
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.027
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.027
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.027
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.027
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.027
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.026
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.026
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.026
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.026
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.026
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.026
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
15 |
0.026
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.026
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.026
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.026
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.026
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.026
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.026
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.026
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.026
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.026
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.025
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.025
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.025
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.025
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.025
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.025
|
|
|
|
metanephric dct cell differentiation
|
GO:0072240 |
3 |
0.025
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.025
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.025
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.025
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.025
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.025
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.025
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.025
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.025
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.025
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.025
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.025
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.025
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.025
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.025
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.025
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.024
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.024
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.024
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.024
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.024
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.024
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.024
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.024
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.024
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.024
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.024
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.024
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.024
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.024
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.024
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.024
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.024
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.024
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.024
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.024
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.024
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.024
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.023
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.023
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.023
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.023
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.023
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.023
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.023
|
Fly |
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.023
|
|
|
|
metanephric capsule morphogenesis
|
GO:0072265 |
1 |
0.023
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.023
|
|
|
|
metanephric capsule formation
|
GO:0072266 |
1 |
0.023
|
|
|
|
adenohypophysis development
|
GO:0021984 |
14 |
0.023
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.023
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.023
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.023
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.023
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.023
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.023
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.023
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.022
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.022
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.022
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.022
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.022
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.022
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.022
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.022
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.022
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.022
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.022
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.022
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.022
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.022
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.022
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.022
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.022
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.022
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.022
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.022
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.022
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.021
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
renal capsule formation
|
GO:0072129 |
1 |
0.021
|
|
|
|
paraxial mesoderm morphogenesis
|
GO:0048340 |
10 |
0.021
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.021
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.021
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.021
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.021
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.021
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.021
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.021
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.021
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.021
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.021
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.021
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.021
|
|
|
|
negative regulation of transcription by glucose
|
GO:0045014 |
1 |
0.021
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.021
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.021
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.021
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.021
|
|
|
|
detection of monosaccharide stimulus
|
GO:0034287 |
1 |
0.021
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.020
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.020
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.020
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.020
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.020
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.020
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.020
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.020
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.020
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.020
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.020
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.020
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.020
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.020
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.020
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.020
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.020
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.020
|
|
